跳至主要内容
临床试验/NL-OMON46590
NL-OMON46590招募中不适用

Rate of progression in USH2A related retinal degeneration - RUSH2A

Jaeb Center For Health Research0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 99(—)

入选标准

  • 2.2.1 Study Participant Inclusion Criteria
  • 1. Willing and able to complete the informed consent process
  • 2. Ability to return for all study visits over 48 months if in the natural history study
  • 3. Age * 8 years
  • 4. At least 2 pathogenic or likely pathogenic mutations in USH2A gene from a clinically certified lab report

排除标准

  • 2.2.2 Study Participant Exclusion Criteria
  • 1. Mutations in genes that cause autosomal dominant RP, X-linked RP, or presence of biallelic mutations in autosomal recessive RP/retinal dystrophy genes other than USH2A
  • 2. Expected to enter experimental treatment trial at any time during this study
  • 3. History of more than 1 year of cumulative treatment, at any time, with an agent associated with pigmentary retinopathy (including hydroxychloroquine, chloroquine, thioridazine, and deferoxamine)

研究者

发起方
Jaeb Center For Health Research

相似试验